Japan India hospital covid-19 Government patient Japan India

Glenmark begins clinical trials of potential covid drug

Reading now: 997
www.livemint.com

More than 10 leading government and private hospitals have been enrolled for the trials, the company said in a regulatory exchange filing Glenmark Pharmaceuticals Ltd said Tuesday it has started phase 3 clinical trials in India for its generic antiviral drug favipiravir to treat mild to moderate covid-19 and expects to complete the study by August.

Drug controller general of India V.G. Somani had in late April approved Glenmark’s plan to conduct the trials. More than 10 leading government and private hospitals have been enrolled for the trials, the company said in a regulatory exchange filing.

Favipiravir is a generic version of Avigan of Japan’s Fujifilm Toyama Chemical Co. Ltd, a subsidiary of Fujifilm Corp. Favipiravir has shown some

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA